{"id":"W4389279939","doi":"10.1016/j.annonc.2023.10.132","title":"LBA3 Phase III study of neoadjuvant pembrolizumab or placebo plus chemotherapy followed by adjuvant pembrolizumab or placebo for early-stage triple-negative breast cancer (TNBC): KEYNOTE-522 Korean subgroup analysis","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Pembrolizumab; Triple-negative breast cancer; Placebo; Oncology; Internal medicine; Breast cancer; Subgroup analysis; Adjuvant; Chemotherapy; Adjuvant chemotherapy; Stage (stratigraphy); Cancer; Meta-analysis; Immunotherapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002563207,0.002231937,0.005070276,0.0005904813,0.0006126906,0.001547847,0.001054436,0.001308505,0.006849351],"category_scores_gemma":[0.002160901,0.0007934735,0.007849517,0.0007400957,0.0006192019,0.0009829075,0.0007406446,0.003088836,0.001277386],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001317657,"about_ca_system_score_gemma":0.002100691,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002937621,"about_ca_topic_score_gemma":0.009407349,"domain_scores_codex":[0.9990323,0.0004593118,0.00008910234,0.0001737556,0.00007991577,0.0001656424],"domain_scores_gemma":[0.9993691,0.0001586622,0.0001363084,0.0001072115,0.00007113699,0.0001576606],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9627154,0.001655803,0.001471402,0.001941992,0.01520506,0.00003675938,0.0000496776,0.0004239279,0.002621774,0.0001228583,0.002103439,0.0116519],"study_design_scores_gemma":[0.9393811,0.02684247,0.007227385,0.0001659966,0.02131712,0.00004889257,0.00008051151,0.00057467,0.0006171898,0.0004015947,0.003289639,0.00005362092],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8932889,0.06032138,0.003936443,0.002804785,0.004362665,0.01188823,0.01467056,0.0004896745,0.008237379],"genre_scores_gemma":[0.9541041,0.0111656,0.003130961,0.00297738,0.001016838,0.01029273,0.007047033,0.0001172797,0.01014816],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006849351,"threshold_uncertainty_score":0.02291334,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06947741953422655,"score_gpt":0.4134884706244978,"score_spread":0.3440110510902712,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}